Heart biometry and allometry in rats submitted to nitric oxide synthesis blockade and treatment with antihypertensive drugs

Annals of Anatomy

Volumn 183, Issue 2, 2001, Pages 171-176

  Mandarim de Lacerda, C A ^a   Pereira, L M M ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Allometry; Cardiac hypertrophy; Hypertension; Morphometry; Nitric oxide

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL; MINERAL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SPIRONOLACTONE; VERAPAMIL; VITAMIN;

ALLOMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMETRY; BLOOD PRESSURE REGULATION; BODY MASS; CONTROLLED STUDY; DRUG EFFECT; HEART; HEART HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HEART RIGHT VENTRICLE VOLUME; HEART VOLUME; HEART WEIGHT; MALE; NONHUMAN; RAT; SYNTHESIS; TAIL;

ANIMALIA;

EID: 0035079226     PISSN: 09409602     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-9602(01)80043-1     Document Type: Article

References (46)

1. ACE inhibitor ramipril is more effective than the β-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study
2. Cardiac weight in hypertension induced by nitric oxide synthase blockade
3. Myocardial infarction and nitric oxide
4. Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease, in vivo and in vitro studies on collagen matrix regulation
5. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism
6. Long-term nitric oxide synthase inhibition and distensibility of carotid artery in infant rats
7. Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats
8. Long-term inhibition of NO synthase induces cardiac hypertrophy with decrease in adrenergic innervation
9. Cellular mechanisms of cardiac hypertrophy
10. Allometry and size in ontogeny and phylogeny
11. Bivariate allometry, interval estimation of the slopes of the ordinary and standardized normal major axes and structural relationship
12. Heart failure from the point of view of quantitative anatomy
13. Molecular mechanisms of cardiac myocardial remodeling during aging. Role of apoptosis
14. Human mandibular prenatal growth, bivariate and multivariate growth allometry comparing different mandibular dimensions
15. Stereology of the myocardium in hypertensive rats under chronic inhibition of nitric oxide synthesis
16. Effects of ACE inhibition and beta-blockade on collagen remodeling in the heart of bio 14.6 hamsters
17. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats
18. Endogenous nitric oxide, physiology, pathology and clinical relevance
19. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease
20. Nitric oxide as a secretory product of mammalian cells
21. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats
22. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor
23. Quantitative examination of the cardiac myocytes in hypertensives rats under chronic inhibition of nitric oxide synthesis
24. Myocardial microcirculation stereological changes in rats subjected to nitric oxide synthesis inhibition
25. Stereology of the myocardium in hypertensive rats. Differences in relation to the time of inhibition of nitric oxide synthesis
26. Stereology and immunohistochemistry of the myocardium in experimental hypertension: Long-term and low-dosage administration of inhibitor of the nitric oxide synthesis
27. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone, an insight into endotoxin shock
28. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension
29. A simple method for volumetry of organs in quantitative stereology
30. Association between persistent pressure overload and ventricular arrhythmias in essential hypertension
31. Effects of enalapril and amlodipine on small-artery structure and composition and on endothelial dysfunction in spontaneously hypertensive rats
32. Lisinopril reverse left ventricular hypertrophy through improved aortic compliance
33. Left ventricular hypertrophy regression as a process with variable biological implications
34. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase
35. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rat
36. Pathological hypertrophy and cardiac interstitium, fibrosis and renin-angiotensin-aldosterone system
37. Efficient inhibition of the development of cardiac remodeling by a long-acting calcium antagonist amilodipine